These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 36432641)

  • 1. Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib.
    Dharani S; Mohamed EM; Khuroo T; Rahman Z; Khan MA
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectroscopic characterization and pharmacokinetic evaluation of amorphous solid dispersions of glibenclamide for bioavailability enhancement in Wistar rats.
    Mir KB; Abrol V; Singh N; Khan NA; Dar AA; Alahmadi TA; Ansari MJ
    Biomed Chromatogr; 2024 Aug; 38(8):e5901. PubMed ID: 38816948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Stabilized Amorphous Solid Dispersions to Improve Oral Olaparib Absorption.
    Yun T; Lee S; Yun S; Cho D; Bang K; Kim K
    Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray-Dried Amorphous Solid Dispersions of Atorvastatin Calcium for Improved Supersaturation and Oral Bioavailability.
    Kwon J; Giri BR; Song ES; Bae J; Lee J; Kim DW
    Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31500147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The baicalein amorphous solid dispersion to enhance the dissolution and bioavailability and effects on growth performance, meat quality, antioxidant capacity and intestinal flora in Taihang chickens.
    Gao J; Fan Y; Lu C; Zhao X; He X
    Poult Sci; 2024 Jul; 103(7):103768. PubMed ID: 38703758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability.
    Wang Z; Sun M; Liu T; Gao Z; Ye Q; Tan X; Hou Y; Sun J; Wang D; He Z
    Asian J Pharm Sci; 2019 Jan; 14(1):95-103. PubMed ID: 32104442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Amorphous Solid Dispersion of Chrysin in Plasdone
    Wang C; Liu X; Zhao R; Yang M; Liu W; Dai Q; Bao X; Chen Y; Ma J
    Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of spray-dried amorphous solid dispersions of tadalafil using glycyrrhizin for enhanced dissolution and aphrodisiac activity in male rats.
    Muqtader Ahmed M; Fatima F; Abul Kalam M; Alshamsan A; Soliman GA; Shaikh AA; Alshahrani SM; Aldawsari MF; Bhatia S; Khalid Anwer M
    Saudi Pharm J; 2020 Dec; 28(12):1817-1826. PubMed ID: 33424269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro and In Vivo testing of 3D-Printed Amorphous Lopinavir Printlets by Selective Laser Sinitering: Improved Bioavailability of a Poorly Soluble Drug.
    Kayalar C; Helal N; Mohamed EM; Dharani S; Khuroo T; Kuttolamadom MA; Rahman Z; Khan MA
    AAPS PharmSciTech; 2024 Jan; 25(1):20. PubMed ID: 38267637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Bioavailability and Reduced Variability of Dasatinib and Sorafenib with a Novel Amorphous Solid Dispersion Technology Platform.
    Lennernäs H; Brisander M; Liljebris C; Jesson G; Andersson P
    Clin Pharmacol Drug Dev; 2024 May; ():. PubMed ID: 38808617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Characterization of Lutein Co-Amorphous Formulation with Enhanced Solubility and Dissolution.
    Song X; Luo Y; Zhao W; Liu S; Wang Y; Zhang H
    Foods; 2024 Jun; 13(13):. PubMed ID: 38998535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-micellizing solid dispersion of tacrolimus: Physicochemical and pharmacokinetic characterization.
    Makino K; Tsukada R; Kambayashi A; Yamada K; Sato H; Onoue S
    Biopharm Drug Dispos; 2023 Dec; 44(6):387-395. PubMed ID: 37526477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric Amorphous Solid Dispersions of Dasatinib: Formulation and Ecotoxicological Assessment.
    Sokač K; Miloloža M; Kučić Grgić D; Žižek K
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case study: cremophor EL-based liquid formulations as simple substitutes for amorphous solid dispersions in early preclinical in vivo studies.
    Sigfridsson K; Zhang X; Llinas A
    J Pharm Pharmacol; 2024 Jul; ():. PubMed ID: 39045868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability Enhancement.
    Yarlagadda DL; Das S; Anand Vullendula SK; Manandhar S; Dengale SJ; Ranganath Pai KS; Bhat K
    Mol Pharm; 2024 Jul; ():. PubMed ID: 39049477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of stabilization mechanisms in β-lactoglobulin-based amorphous solid dispersions by experimental and computational approaches.
    Zhuo X; Foderà V; Larsson P; Schaal Z; Bergström CAS; Löbmann K; Kabedev A
    Eur J Pharm Sci; 2024 Jan; 192():106639. PubMed ID: 37967658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Formulation Approaches of Amorphous Solid Dispersions: Significance of Powder Flow Properties and Feeding Performance.
    Szabó E; Démuth B; Galata DL; Vass P; Hirsch E; Csontos I; Marosi G; Nagy ZK
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31817454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in Solid Dispersions.
    Ortiz KS; Hernández Espinell JR; Ortiz Torres D; Lopéz-Mejías V; Stelzer T
    Cryst Growth Des; 2020 Feb; 20(2):713-722. PubMed ID: 38107251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the Influence of Anti-Solvent Precipitation Parameters on the Physical Stability of Amorphous Solids.
    Li Z; Gong Z; Zhang B; Nawaz A
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization.
    Rodríguez I; Gautam R; Tinoco AD
    Biomimetics (Basel); 2020 Dec; 6(1):. PubMed ID: 33396786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.